Lambot, Adelpa .

HRN: 28-62-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CEFUROXIME 500MG (TAB)
02/24/2026
03/02/2026
PO
500 Mg
BID
Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: